Navigation Links
Medisafe 1 Technologies in Advanced Negotiations for $7MM Perpetual License Sale
Date:8/30/2012

JERUSALEM, August 30, 2012 /PRNewswire/ --

Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company is in advanced negotiations to enter into a non-exclusive perpetual license agreement to transfer rights for the full commercialization, marketing and distribution of its patented medicinal locking mechanism and bar-code matching system.

Terms of the sale include a one-time payment of $7MM.  The perpetual license agreement is anticipated to be signed within 60 days, pending the results of a due diligence study by the intended buyer.

The patented technology physically prevents medication administration errors in hospitals.  The device includes a syringe locking mechanism that works in concert with a bar-code reader and database system.  

The device electronically confirms whether the syringe held by a medical practitioner contains the correct medication and dosage that has been prescribed to a particular patient, before allowing that medication to be physically administered.

"We hope to soon announce the closing of the perpetual license sale, which will enable the wider distribution of our technology, and to fulfill the principles of our business plan," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "The sale, if completed will infuse Medisafe with much needed capital to further develop and market our proprietary, life-saving devices."


About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle.  Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
'/>"/>

SOURCE Medisafe 1 Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Medisafe 1 Technologies Corp has of Today Acquired 3,100,000 Shares and Continues to Acquire Shares Under its $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share to Facilitate its On-going Acquisitions Activity Plan
2. Global E-Clinical Trial Technologies Industry
3. BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
4. Antifungal Drugs: Technologies and Global Markets
5. Cleveland Clinics 2012 Medical Innovation Summit Highlights Orthopaedic Technologies
6. Breast Cancer Diagnostic and Drug Technologies: Global Markets
7. ARAMARK Healthcare Technologies Taps Robert Steele to Lead ReMedPar
8. Montmed to Participate in 2013 Advanced Technologies and Treatments for Diabetes Conference
9. U.S. Navy Awards Multi-Million Dollar Contract to Innovation for Pharmacy Automation Technologies
10. Technologies Impacting the Future of Healthcare
11. ECRI Institute Helps Hospitals Design Spaces for Current and Future Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... - New Solution That Makes ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC PACK" ... yen or $5,000 (without tax /including two pairs of JINS ... a dedicated solution of "JINS MEME" to academic researchers, and ... generated by electrooculography and six-axis sensors without API. (*Physiological data ...
(Date:11/26/2014)... 2014  Thoratec Corporation (NASDAQ: THOR ), ... to save, support and restore failing hearts, said today ... On Tuesday, December 2, the company will ... Healthcare Conference.  D. Keith Grossman , President and ... company beginning at 11:30 a.m., Eastern Standard Time (8:30 ...
(Date:11/26/2014)... 2014   Royal Philips (NYSE: ... availability of its portfolio of diagnostic X-ray ... Opta[i] , ProGrade and PrimaryDiagnost[ii]. With new releases ... the U.S., and availability of all these solutions ... customers innovative solutions designed to meet the needs ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Thoratec Announces Presentations At Investor Conferences For December 2014 2Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3
... Greater Than 50% Response Rate and 100% Disease Control Rate Observed ... Patients with Medullary Thyroid Cancer, ... encouraging new data from an ongoing phase 1 clinical trial of,XL184, ... with advanced malignancies. The maximum tolerated dose (MTD) for,XL184 has been ...
... in Management of Transplant Recipients with Cancer, ... in post-transplant patients with cancer is challenging.,Clinicians must ... while,simultaneously monitoring the impact of chemotherapeutic agents on ... management of such patients will be,presented today at ...
Cached Medicine Technology:Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 2Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 3Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 4Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 5Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 6Penn State Hershey Transplant Program Uses Assay to Monitor Cell-Mediated Immunity 2
(Date:11/27/2014)... "As a nurse I see patients every ... incontinence," said an inventor from Whiting, N.J. "I put ... to prevent leakage and keep them dry and comfortable." ... This prevents stains on pants, skirts and bottoms, which ... that the individual has time to get to the ...
(Date:11/27/2014)... 27, 2014 Nearly 1,100 Risperdal ... in a consolidated litigation now underway in Pennsylvania ... Documents recently updated in the Philadelphia Court of ... state proceeding, all of which involve a drug ... psychiatric conditions. Many of the cases in this ...
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. 26, 2014 ... a second language, new research suggests. But anyone who tries ... brain boost, the small study finds. The brain ... Ping Li, co-director of the Center for Brain, Behavior and ... Li said, that "the brain networks of the more successful ...
(Date:11/27/2014)... News) -- Most babies and young children don,t need ... and Drug Administration says. Over-the-counter (OTC) cold and ... than 2 because they could cause serious and potentially ... average about three colds a year, but children get ... might want to give them pain relievers, decongestants and ...
(Date:11/27/2014)... Thompson HealthDay Reporter WEDNESDAY, ... appears to be safe and produces an immune system response ... early clinical trial results reported by the U.S. National Institutes ... trial for the vaccine paves the way for field-testing it ... Leone as early as January, said Dr. Anthony Fauci, director ...
Breaking Medicine News(10 mins):Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3
... UPTON, NY The more gray matter you have in ... ability to evaluate rewards and consequences. That may seem like ... U.S. Department of Energy,s Brookhaven National Laboratory is the first ... people and the impairment of both structure and function ...
... News) -- ,Creative thinkers are more likely to cheat ... an original thinker increases a person,s ability to rationalize ... and Duke University researchers conducted five experiments to determine ... could justify their dishonesty. The findings appear online in ...
... London suggests that many cases of diabetes could be prevented ... published today in the British Medical Journal *, shows ... reasonable accuracy who will develop diabetes but almost none are ... tools were used by GPs and members of the public, ...
... Mann HealthDay Reporter , MONDAY, Nov. 28 (HealthDay ... to open blocked heart arteries will land back in the ... a second, related report found that rehospitalization after angioplasty or ... procedure. Both studies, which appear in the Nov. 28 ...
... Ga. The same filtered light that enables sunglasses ... detect early signs of cervical cancer, reducing unnecessary biopsies ... traditional radial light which scatters in all directions, said ... Director of the Gynecologic Cancer Prevention Center at Georgia ...
... history of breast cancer are just as likely to develop ... of the disease, according to a study presented today at ... (RSNA). These findings indicate that women in this age group ... cancer screening guidelines issued by the U.S. Preventive Services Task ...
Cached Medicine News:Health News:Gray matter in brain's control center linked to ability to process reward 2Health News:Gray matter in brain's control center linked to ability to process reward 3Health News:Creative Minds More Prone to Cheating 2Health News:Tools for predicting diabetes exist but are not used, research shows 2Health News:Angioplasty Patients May Be at Risk for Rehospitalization 2Health News:Angioplasty Patients May Be at Risk for Rehospitalization 3Health News:Polarized filter may reduce unnecessary cervical biopsies and surgeries 2Health News:New study supports mammography screening at 40 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: